| CEUEX | FCIKX | CEUEX / FCIKX | |
| Total Expense Ratio | 1.08 | 1.49 | 72% |
| Annual Report Gross Expense Ratio | 1.08 | 1.72 | 63% |
| Fund Existence | 24 years | 2 years | - |
| Gain YTD | 5.611 | -1.178 | -476% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 135B | 725M | 18,621% |
| Annual Yield % from dividends | 2.50 | 0.22 | 1,147% |
| Returns for 1 year | 17.65 | 5.43 | 325% |
| Returns for 3 years | 24.00 | N/A | - |
| Returns for 5 years | -4.88 | N/A | - |
| Returns for 10 years | 70.29 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RMT | 11.63 | 0.04 | +0.35% |
| Royce Micro-Cap Trust | |||
| PMSE | 25.58 | N/A | N/A |
| PGIM S&P 500 Max Buffer ETF - September | |||
| BSMW | 25.33 | -0.01 | -0.04% |
| Invesco BulletShares 2032 Muncpl Bd ETF | |||
| SPSM | 49.99 | -0.03 | -0.06% |
| State Street SPDR Port S&P 600 Sm CpETF | |||
| HELX | 36.54 | -0.24 | -0.66% |
| Franklin Genomic Advancements ETF | |||